Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group.

[1]  E. Ohman,et al.  Temporal creatine kinase curves in acute myocardial infarction. Implications of a good empiric fit with the log-normal function. , 1993, American journal of clinical pathology.

[2]  B. Sobel,et al.  Timing of coronary recanalization. Paradigms, paradoxes, and pertinence. , 1992, Circulation.

[3]  R. Califf,et al.  Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group. , 1992, Journal of the American College of Cardiology.

[4]  H. Schieffer,et al.  Optimised function for determining time to peak creatine kinase and creatine kinase-MB as non-invasive reperfusion indicators after thrombolytic therapy in acute myocardial infarction. , 1990, Cardiovascular research.

[5]  R. Reneman,et al.  Complete recovery in plasma of enzymes lost from the heart after permanent coronary artery occlusion in the dog. , 1990, Circulation.

[6]  R. Roberts.  Enzymatic estimation of infarct size. Thrombolysis induced its demise: will it now rekindle its renaissance? , 1990, Circulation.

[7]  J. Bigger,et al.  A physiologically based model of creatine kinase-MB release in reperfusion of acute myocardial infarction. , 1989, The American journal of cardiology.

[8]  P. Grande,et al.  Estimation of Acute Myocardial Infarct Size in Man by Serum CK‐MB Measurements , 1982, Circulation.

[9]  P. H. Petersen,et al.  Plasma enzymes in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information. , 1981, Scandinavian journal of clinical and laboratory investigation.

[10]  E. Gilpin,et al.  The creatine kinase curve area and peak creatine kinase after acute myocardial infarction: usefulness and limitations. , 1981, American heart journal.

[11]  F. Cobb,et al.  Effect of Extension of Infarction on Serial CK Activity , 1979, Circulation.

[12]  S. Vatner,et al.  Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase. , 1978, The Journal of clinical investigation.

[13]  C. Roe.  Validity of estimating myocardial infarct size from serial measurements of enzyme activity in the serum. , 1977, Clinical chemistry.

[14]  Arthur S Slutsky.  Individualized Values for the Disappearance Rate Parameter (Kd) in the Enzymatic Estimation of Infarct Size: A Critique , 1977, Circulation.

[15]  C. Starmer,et al.  The Relationship between Enzymatic and Histologic Estimates of the Extent of Myocardial Infarction in Conscious Dogs with Permanent Coronary Occlusion , 1977, Circulation.

[16]  J. Jarmakani,et al.  Effect of reperfusion on myocardial infarct, and the accuracy of estimating infarct size from serum creatine phosphokinase in the dog. , 1976, Cardiovascular research.

[17]  B. Sobel,et al.  An Improved Basis for Enzymatic Estimation of Infarct Size , 1975, Circulation.

[18]  C. Starmer,et al.  A sensitivity analysis of enzymatic estimation of infarct size. , 1975, Circulation.

[19]  C. W. Small,et al.  Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction. , 1975, Circulation.

[20]  J. Covell,et al.  Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction. , 1973, The Journal of clinical investigation.

[21]  M. Gertler,et al.  Ischemic Heart Disease: Insulin, Carbohydrate, and Lipid Interrelationships , 1972, Circulation.

[22]  B. Sobel,et al.  Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. , 1971, The Journal of clinical investigation.

[23]  H. Hemker,et al.  Quantitation of enzyme release from infarcted heart muscle. , 1971, British heart journal.